Light Therapy Market Size, Share & Trends Analysis Report By Product (Light Boxes, Floor & Desk Lamps, Light Visors, Dawn Simulators, Light Therapy Bulbs, Handheld Devices, Other Products), By Light Type (White, Blue, Red, Others), By Application (Vitamin D Deficiency, Seasonal Affective Disorder (SAD), Depression & Sleep-cycle Disorders, Skin Disorders, Other Application), By End User (Hospitals, Dermatology Clinics, Home Care Settings, Other End Users) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Light Therapy Market Size

The global light therapy market size was valued at USD 1.03 billion in 2025 and is projected to grow from USD 1.08 billion in 2026 to USD 1.51 billion by 2034, registering a CAGR of 4.37% during the forecast period from 2026 to 2034. North America dominated the light therapy market with a market share of 43.2% in 2025.

The light therapy market is growing steadily as demand increases for non-invasive treatment of conditions such as seasonal affective disorder, acne, psoriasis, and sleep disorders. Rising awareness of mental health encourages adoption in both clinical and home settings. In 2025, Philips expanded its SmartSleep portfolio with app-connected wake-up lights that help regulate circadian rhythms, showing strong consumer-focused innovation. At the same time, LumeBox gained popularity with portable devices designed for SAD and jet lag, reflecting growing demand for convenient solutions. Improvements in LED-based multi-wavelength technology increase treatment effectiveness and flexibility. Collaborations between device manufacturers and dermatology clinics support product validation and trust. Expanding e-commerce platforms boost global accessibility. However, high device costs and limited reimbursement policies continue to restrict wider adoption in developing regions, highlighting the need for affordable and clinically proven light therapy solutions.

By Product

The light boxes segment dominates the product market, accounting for 27.06% in 2025 due to strong clinical use in treating seasonal affective disorder and circadian rhythm disorders with standardized 10,000-lux exposure therapy. Low cost and easy accessibility compared to wearable devices, making it widely adopted in home care settings. Strong hospital and telehealth prescription support increases patient trust and repeat usage across North America and Europe.

The handheld devices segment is expected to grow at a CAGR of 4.85% during the forecast period. This growth is accelerated by rising demand for portable dermatology solutions, especially for acne and pigmentation management in urban populations. Increasing adoption among sports physiotherapy users for localized pain and inflammation relief using red-light handheld applicators collectively drives growth in the handheld devices segment.

Request Customizationto receive a tailored report.

By Light Type

The blue segment dominated the market with a share of 33.61% in 2025, owing to its strong bactericidal action against Cutibacterium acne, which makes it highly effective for acne and oily skin conditions. It is preferred because it works at shallow skin depth, targeting surface-level infections without damaging deeper tissues, ensuring safe, non-invasive treatment. Short treatment time and compatibility with handheld devices make it convenient for daily skincare routines.

The red segment is expected to grow at a CAGR of 5.12% during the forecast period because of expanding use in musculoskeletal and deep-tissue therapy applications beyond dermatology. It is increasingly adopted in physiotherapy and sports recovery clinics because it helps reduce muscle soreness, joint stiffness, and inflammation after injury. Increasing integration in wellness and biohacking routines, where consumers use red light beds for sleep improvement and energy regulation, also boosts market adoption.

By Application

The skin disorders segment dominated the market, accounting for 31.42% revenue share in 2025. This dominance can be attributed to the standardized use of narrowband UV and LED-based protocols in dermatology clinics, where controlled dosing improves treatment consistency for long-term skin management. For example, hospital dermatology units routinely use phototherapy cabins for psoriasis plaque clearance and vitiligo repigmentation as part of long-term care programs. Rising preference for non-drug-based dermatology care supports the adoption of light therapy devices.

The depression & sleep-cycle disorders segment is projected to grow at a CAGR of 4.97% during the forecast period, as these conditions show rising global prevalence and strong clinical linkage with circadian disruption. Insomnia alone affects up to 10% of the global population, making it one of the most common sleep disorders, driving light therapy demand. Depression is also frequently associated with sleep and circadian rhythm disruption, where irregular light exposure worsens symptoms and delays recovery.

By End User

The dermatology clinics segment dominated the market, accounting for 40.73% revenue share in 2025. This growth is supported by high patient inflow, procedural combination therapy, advanced phototherapy infrastructure, post-laser recovery usage, and standardized treatment protocols for acne, psoriasis, and pigmentation disorders. Clinics also benefit from repeat treatment cycles and strong adoption of FDA-cleared light devices, making them the primary end-use setting for controlled and supervised light therapy applications globally.

The home care settings segment is projected to grow at a CAGR of 5.07% during the forecast period due to the adoption of self-managed dermatology and wellness devices in North America, where high out-of-pocket spending encourages at-home acne and seasonal affective disorder treatment using light boxes and LED masks. In Europe, a rising aging population and preference for non-clinical chronic skin management support home phototherapy use for conditions like psoriasis and eczema, especially in countries like Germany and the UK.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America: Market Leadership through Adoption in Corporate Wellness Programs and High Prevalence of Seasonal Affective Disorder

The North America light therapy market accounted for a revenue share of 43.20% in 2025 due to the high adoption of circadian lighting in corporate wellness programs, where tech companies and hospitals use tunable LED systems to reduce fatigue and improve productivity. For example, in 2025, workplaces in the US increasingly installed smart daylight-mimicking lighting systems integrated with IoT sensors to regulate employee alertness during winter months. Strong clinical use of FDA-cleared dermatology light devices in cosmetic clinics for acne and anti-aging treatments, widely adopted in urban US centers. These factors collectively drive regional market growth.

The US market is growing due to the rapid adoption of VA and military rehabilitation programs using red and near-infrared photobiomodulation for pain management, wound healing, and traumatic brain injury recovery in veterans. Another key factor is integration of light therapy in telehealth sleep clinics, where US-based platforms prescribe circadian light devices alongside virtual cognitive behavioral therapy for insomnia. In addition, strong demand from high-altitude and aviation professionals, such as pilots and flight crews, drives use of portable devices to manage jet lag and circadian misalignment during frequent cross-time-zone travel.

Canada’s market benefits from the high prevalence of seasonal affective disorder, especially in northern provinces like Manitoba, Yukon, and Newfoundland, where long winters reduce sunlight exposure for several months. Clinical surveys show SAD affects about 2-3% of Canadians, and seasonal low mood affects up to 15% of the population during winter, increasing demand for light therapy lamps. Another key factor is circadian disruption among shift workers in healthcare and mining sectors, where light therapy is used to regulate sleep cycles and reduce fatigue.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific: Fastest Growth Driven by Rising Prevalence of Sleep Disorders and Rapid Integration of LED Phototherapy

The Asia Pacific light therapy market is expected to register the fastest growth with a CAGR of 5.88% during the forecast period, due to rising urban sleep disorders caused by high population density and long working hours in Japan and South Korea, where shift work culture is highly common. For example, large Japanese corporations like office-based IT and manufacturing firms increasingly install circadian lighting systems in workplaces to reduce employee fatigue and improve alertness during night shifts. Another key driver is the rapid expansion of dermatology clinics in China and India using LED-based therapy for acne and pigmentation treatment, supported by high skin disorder prevalence and growing aesthetic awareness.

The Chinese market is growing due to rapid integration of LED phototherapy into high-throughput medical aesthetic chains that operate standardized treatment protocols for acne, pigmentation, and post-laser recovery across tier-1 cities such as Shanghai, Beijing, and Shenzhen. Increasing adoption in ophthalmology clinics for myopia-related eye strain management among students, where low-level red light devices are used as supportive therapy alongside vision correction programs. In addition, China’s strong domestic manufacturing ecosystem in Shenzhen enables fast commercialization of low-cost wearable light masks, accelerating product adoption through e-commerce.

The India light therapy market is driven by the rising burden of chronic pigmentary skin disorders, such as psoriasis and vitiligo, which require repeated non-invasive phototherapy sessions. Clinical dermatology studies in India report psoriasis prevalence around 8% and vitiligo near 1% of dermatology patients in hospital-based settings, showing a consistent treatment need in outpatient care networks. The growing availability of portable home-use phototherapy devices, allowing patients in tier-2 cities to continue maintenance treatment outside hospitals, improves accessibility and supports market growth in this country.

Competitive Landscape

The light therapy market is moderately consolidated, with global companies and niche brands competing actively across clinical and consumer segments. Leading players such as Koninklijke Philips N.V., Beurer GmbH, and Verilux Inc. offer diverse product portfolios, strong brand presence, and wide distribution networks. Specialized firms like BioPhotas Inc. and Northern Light Technologies focus on targeted applications such as skincare and seasonal affective disorder. Competition is driven by product innovation, affordability, and multi-functional devices, while partnerships and product launches continue to support global market growth and adoption across regions.

List of Key and Emerging Players in Light Therapy Market